Suvoda Enhances Clinical Trial Participation with Expanded Travel Solutions

Enhancing Clinical Trial Participation with Suvoda's Greenphire Travel

Suvoda, a leading clinical trial technology company, is taking significant steps to enhance patient participation in clinical trials through its expanded Greenphire Travel program. This innovative platform aims to mitigate logistical barriers that often hinder patient involvement.

One of the core challenges that clinical trial participants face is the travel hassle. According to a recent study by CISCRP, nearly 49% of participants cited travel to the trial site as a significant barrier to maintaining their involvement. Recognizing this issue, Suvoda has developed features that ease the travel process significantly.

Expanding Access to Ridesharing Services

The Greenphire Travel program now includes expanded ridesharing options for trial participants. The integration of services such as Lyft, Uber Health, and Bolt allows participants to book transportation directly through the Suvoda app. This not only streamlines the travel process but also alleviates the burdensome coordination tasks that sites typically handle. Participants can manage their travel itineraries, book eligible rides, and oversee their appointments and payments all in one platform.

According to Elizabeth Smith, Director of Product and Patient Experience at Suvoda, “Clinical trial participants often have to manage significant health challenges in addition to travel logistics. Greenphire Travel eliminates the coordination burden for sites and patients, allowing them to focus on what truly matters—their health and well-being.”

Streamlined Travel Coordination for Sites and Sponsors

Not only does the Greenphire Travel program simplify travel for participants, but it also provides sites with an intuitive workflow for travel requests. This improved interface enhances visibility into travel status and cost for sponsors and Clinical Research Organizations (CROs), offering detailed reports for better decision-making in international trials. Will Wing, Director of Products at Suvoda, emphasizes the need for actionable insights, saying, “As travel requirements grow in complexity, sponsors and sites need integrated, actionable information throughout the study.”

Customizable Support Models

Flexibility is at the heart of the Greenphire Travel service. Suvoda offers two distinct support models to cater to different study needs: a site-managed approach that allows study teams to initiate simple travel requests directly and a more comprehensive Concierge model that provides personalized assistance tailored for complex trials or participants with unique needs. These concierge coordinators are available 24/7 in over 40 countries, ensuring that participants receive localized support throughout their trial experience.

This level of individualized care is especially crucial for patients dealing with severe conditions or involved in rare disease studies. Sponsors can select the appropriate level of service for each trial, ensuring that patients receive the support they require in a format that fits their specific situation.

Accessibility and Zero Upfront Costs

Greenphire Travel’s services are designed to be globally accessible, having supported over 8,400 sites in more than 2,000 trials across 50 countries. Not only are ridesharing options now widely available, but importantly, participants will not need to pay upfront travel costs. Suvoda handles eligible travel expenses in advance, which reduces financial stress for patients and contributes to a seamless trial experience.

Conclusion

With the expansion of the Greenphire Travel program, Suvoda is making strides in addressing an essential aspect of clinical trials: participant mobility. By reducing logistical burdens and enhancing access to travel options, Suvoda ensures that patients can focus on their health while engaging with innovative research. As clinical trials become increasingly complex, such initiatives are crucial to support patient participation and enhance the overall trial experience.

For media inquiries, please contact Robin Abadía, Director of External Communications at Suvoda.